BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 12118839)

  • 21. Emerging drugs for varicella-zoster virus infections.
    Andrei G; Snoeck R
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early relapses of varicella-zoster virus infection in immunocompromised children treated with acyclovir.
    Mészner Z; Gyarmati E; Nyerges G; Simon M; Koller M
    Acta Paediatr Hung; 1990; 30(2):263-70. PubMed ID: 2248805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and treatment of VZV infections in patients with HIV.
    Gershon AA
    Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella in a pediatric heart transplant population on nonsteroid maintenance immunosuppression.
    Dodd DA; Burger J; Edwards KM; Dummer JS
    Pediatrics; 2001 Nov; 108(5):E80. PubMed ID: 11694664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
    Wutzler P
    Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of VZV infection in immunosuppressed patients using antiviral agents.
    Boeckh M
    Herpes; 2006 Nov; 13(3):60-5. PubMed ID: 17147908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Presentation of Herpes Zoster in Immunocompetent and Immunocompromised Hospitalized Children Treated With Acyclovir.
    Kuchar E; Szenborn L; Lis I; Jaroszewska A; Czeladzka J
    J Pediatr Hematol Oncol; 2016 Jul; 38(5):394-7. PubMed ID: 27347778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-consequence models for varicella-zoster virus infections.
    Paul JE; Mauskopf JA; Bell L
    Pharmacotherapy; 1995; 15(5 Pt 2):49S-58S. PubMed ID: 8577631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients.
    Tayyar R; Ho D
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acyclovir therapy of varicella-zoster virus infections in the immunosuppressed children ].
    Peyramond D; Denoyel GA; Bertrand JL; Bertoye A
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):596-602. PubMed ID: 6750532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history and treatment of varicella-zoster in high-risk populations.
    Gnann JW; Whitley RJ
    J Hosp Infect; 1991 Jun; 18 Suppl A():317-29. PubMed ID: 1679798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Childhood herpes zoster.
    Papadopoulos AJ; Birnkrant AP; Schwartz RA; Janniger CK
    Cutis; 2001 Jul; 68(1):21-3. PubMed ID: 11480141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ambulatory management of varicella-zoster virus infection in immunocompromised cancer patients.
    Rolston KV; Manzullo E; Elting L; Frisbee-Hume S; Rodriguez S; Rubenstein EB
    Support Care Cancer; 1998 Jan; 6(1):57-62. PubMed ID: 9458538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS.
    Pahwa S; Biron K; Lim W; Swenson P; Kaplan MH; Sadick N; Pahwa R
    JAMA; 1988 Nov; 260(19):2879-82. PubMed ID: 3184352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Varicella-zoster infection--extreme clinical aspects].
    Maniciuc C; Dorobaţ C; Hurmuzache M; Mihalache D; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):852-5. PubMed ID: 17438887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acyclovir therapy in varicella/zoster diseases in immunocompromised children with cancer].
    Kuhn N; Landbeck G
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):105-9. PubMed ID: 6328285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
    Leung TF; Chik KW; Li CK; Lai H; Shing MM; Chan PK; Lee V; Yuen PM
    Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic understanding and control of varicella-zoster virus infection.
    Asano Y
    Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.